BOHRF Original Authors' Main Conclusions
The original authors' main conclusions are taken from Abstract, Results and
Discussion. They are decided upon by the authors of the BOHRF occupational
asthma guidelines and form part of the guidelines.
After removal from exposure to the offending agent (mean duration of exposure after onset of symptoms before removal 6 years, follow up assessments on average 3.3 years after removal from exposure), 60% of subjects showed a decrease but a persistence of specific bronchial responsiveness to high and low molecular weight agents. 63% of subjects with occupational asthma to high molecular weight agents had a decrease in specific IgE levels. Significant improvement in non-specific bronchial reactivity (NSBR) in 47% of subjects was observed and all subjects reported symptomatic improvement - 2 were asymptomatic.
BOHRF Associated Evidence Statements
The BOHRF occupational asthma guidelines state that this reference is associated
with the following evidence statements
This page is showing the information from the BOHRF occupational asthma guidelines for this reference. To see additional information, including opinions left by users of this website please view the full reference. This page allows users to comment on the reference and suggest it as evidence for questions. These may be the existing questions from the Bohrf occupational asthma guidelines or questions that have been put forward by users of this website.